December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 03, 2024CorporateMulti-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients
December 03, 2024CorporateTerumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support CatheterProvides interventionalists with optimal product choices for more complex radial-to-peripheral procedures
FYE 3/2024 FYE 3/2023 FYE 3/2022 FYE 3/2020 FYE 3/2019 FYE 3/2018 FYE 3/2017 FYE 3/2024 Consolidated Financial Statements (PDF 1.11 MB) FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB) FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB) FYE 3/2020 Consolidated Financial Statements (PDF 1.48 MB) FYE 3/2019 Consolidated Financial Statements (PDF 1.52 MB) FYE 3/2018 Consolidated Financial Statements (PDF 1.77 MB) FYE 3/2017 Consolidated Financial Statements (PDF 2.93 MB) Adobe Reader (free) is required to view PDF files. Download Adobe Reader
FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB)
FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB)
Top
Top